Request Quote

Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Call Now
+125 (895) 658 568
Quick Email
info.help@gmail.com
Office Address
PV3M+X68 Welshpool United Kingdom
  • Home |
  • Axoltis misses the mark in phase 2 ALS study, but still strives to move towards the clinic

Axoltis misses the mark in phase 2 ALS study, but still strives to move towards the clinic

  • September 14, 2026

Axoltis Pharma announced today that its phase 2 trial for amyotrophic lateral sclerosis has missed its primary endpoint.

Leave A Comment

Fields (*) Mark are Required

Recent Posts

Popular Tag

Copyright 2024 - All Rights Reserved By Resonate Group | Designed By Nysut Digital Studios